288 related articles for article (PubMed ID: 24252187)
1. Mild chronic cerebral hypoperfusion induces neurovascular dysfunction, triggering peripheral beta-amyloid brain entry and aggregation.
ElAli A; Thériault P; Préfontaine P; Rivest S
Acta Neuropathol Commun; 2013 Nov; 1():75. PubMed ID: 24252187
[TBL] [Abstract][Full Text] [Related]
2. Neurovascular mechanisms and blood-brain barrier disorder in Alzheimer's disease.
Bell RD; Zlokovic BV
Acta Neuropathol; 2009 Jul; 118(1):103-13. PubMed ID: 19319544
[TBL] [Abstract][Full Text] [Related]
3. Chronic cerebral hypoperfusion alters amyloid-β peptide pools leading to cerebral amyloid angiopathy, microinfarcts and haemorrhages in Tg-SwDI mice.
Salvadores N; Searcy JL; Holland PR; Horsburgh K
Clin Sci (Lond); 2017 Aug; 131(16):2109-2123. PubMed ID: 28667120
[TBL] [Abstract][Full Text] [Related]
4. Neurovascular dysfunction and faulty amyloid β-peptide clearance in Alzheimer disease.
Sagare AP; Bell RD; Zlokovic BV
Cold Spring Harb Perspect Med; 2012 Oct; 2(10):. PubMed ID: 23028132
[TBL] [Abstract][Full Text] [Related]
5. Neurovascular defects and faulty amyloid-β vascular clearance in Alzheimer's disease.
Sagare AP; Bell RD; Zlokovic BV
J Alzheimers Dis; 2013; 33 Suppl 1(0 1):S87-100. PubMed ID: 22751174
[TBL] [Abstract][Full Text] [Related]
6. Role of the blood-brain barrier in the pathogenesis of Alzheimer's disease.
Deane R; Zlokovic BV
Curr Alzheimer Res; 2007 Apr; 4(2):191-7. PubMed ID: 17430246
[TBL] [Abstract][Full Text] [Related]
7. Chronic cerebral hypoperfusion accelerates amyloid beta deposition in APPSwInd transgenic mice.
Kitaguchi H; Tomimoto H; Ihara M; Shibata M; Uemura K; Kalaria RN; Kihara T; Asada-Utsugi M; Kinoshita A; Takahashi R
Brain Res; 2009 Oct; 1294():202-10. PubMed ID: 19646974
[TBL] [Abstract][Full Text] [Related]
8. Transplantation of in vitro cultured endothelial progenitor cells repairs the blood-brain barrier and improves cognitive function of APP/PS1 transgenic AD mice.
Zhang S; Zhi Y; Li F; Huang S; Gao H; Han Z; Ge X; Li D; Chen F; Kong X; Lei P
J Neurol Sci; 2018 Apr; 387():6-15. PubMed ID: 29571873
[TBL] [Abstract][Full Text] [Related]
9. The Effect of Chronic Cerebral Hypoperfusion on Amyloid-β Metabolism in a Transgenic Mouse Model of Alzheimer's Disease (PS1V97L).
Yang H; Hou T; Wang W; Luo Y; Yan F; Jia J
J Alzheimers Dis; 2018; 62(4):1609-1621. PubMed ID: 29614686
[TBL] [Abstract][Full Text] [Related]
10. Age-Dependent Regulation of the Blood-Brain Barrier Influx/Efflux Equilibrium of Amyloid-β Peptide in a Mouse Model of Alzheimer's Disease (3xTg-AD).
Do TM; Dodacki A; Alata W; Calon F; Nicolic S; Scherrmann JM; Farinotti R; Bourasset F
J Alzheimers Dis; 2016; 49(2):287-300. PubMed ID: 26484906
[TBL] [Abstract][Full Text] [Related]
11. Insoluble Vascular Amyloid Deposits Trigger Disruption of the Neurovascular Unit in Alzheimer's Disease Brains.
Soto-Rojas LO; Campa-Córdoba BB; Harrington CR; Salas-Casas A; Hernandes-Alejandro M; Villanueva-Fierro I; Bravo-Muñoz M; Garcés-Ramírez L; De La Cruz-López F; Ontiveros-Torres MÁ; Gevorkian G; Pacheco-Herrero M; Luna-Muñoz J
Int J Mol Sci; 2021 Apr; 22(7):. PubMed ID: 33915754
[TBL] [Abstract][Full Text] [Related]
12. ABCG2- and ABCG4-mediated efflux of amyloid-β peptide 1-40 at the mouse blood-brain barrier.
Do TM; Noel-Hudson MS; Ribes S; Besengez C; Smirnova M; Cisternino S; Buyse M; Calon F; Chimini G; Chacun H; Scherrmann JM; Farinotti R; Bourasset F
J Alzheimers Dis; 2012; 30(1):155-66. PubMed ID: 22391220
[TBL] [Abstract][Full Text] [Related]
13. β-Amyloid, cholinergic transmission, and cerebrovascular system -- a developmental study in a mouse model of Alzheimer's disease.
Kuznetsova E; Schliebs R
Curr Pharm Des; 2013; 19(38):6749-65. PubMed ID: 23530514
[TBL] [Abstract][Full Text] [Related]
14. Alzheimer's Disease: The Link Between Amyloid-β and Neurovascular Dysfunction.
Solis E; Hascup KN; Hascup ER
J Alzheimers Dis; 2020; 76(4):1179-1198. PubMed ID: 32597813
[TBL] [Abstract][Full Text] [Related]
15. Accelerated accumulation of fibrinogen peptide chains with Aβ deposition in Alzheimer's disease (AD) mice and human AD brains.
Bian Z; Yamashita T; Shi X; Feng T; Yu H; Hu X; Hu X; Bian Y; Sun H; Tadokoro K; Takemoto M; Omote Y; Morihara R; Abe K
Brain Res; 2021 Sep; 1767():147569. PubMed ID: 34197775
[TBL] [Abstract][Full Text] [Related]
16. Chronic Cerebral Hypoperfusion Activates the Coagulation and Complement Cascades in Alzheimer's Disease Mice.
Shi X; Ohta Y; Liu X; Shang J; Morihara R; Nakano Y; Feng T; Huang Y; Sato K; Takemoto M; Hishikawa N; Yamashita T; Abe K
Neuroscience; 2019 Sep; 416():126-136. PubMed ID: 31394196
[TBL] [Abstract][Full Text] [Related]
17. Chronic cerebral hypoperfusion-induced impairment of Aβ clearance requires HB-EGF-dependent sequential activation of HIF1α and MMP9.
Ashok A; Rai NK; Raza W; Pandey R; Bandyopadhyay S
Neurobiol Dis; 2016 Nov; 95():179-93. PubMed ID: 27431094
[TBL] [Abstract][Full Text] [Related]
18. Amyloid Beta-Mediated Neurovascular Toxicity in Alzheimer's Disease.
Banerjee S; Banerjee S
Methods Mol Biol; 2024; 2761():355-372. PubMed ID: 38427250
[TBL] [Abstract][Full Text] [Related]
19. Chronic cerebral hypoperfusion alters amyloid-β transport related proteins in the cortical blood vessels of Alzheimer's disease model mouse.
Shang J; Yamashita T; Tian F; Li X; Liu X; Shi X; Nakano Y; Tsunoda K; Nomura E; Sasaki R; Tadokoro K; Sato K; Takemoto M; Hishikawa N; Ohta Y; Abe K
Brain Res; 2019 Nov; 1723():146379. PubMed ID: 31415766
[TBL] [Abstract][Full Text] [Related]
20. Interactions between Beta-Amyloid and Pericytes in Alzheimer's Disease.
Li YY; Guo DD; Duan RN; Li Y
Front Biosci (Landmark Ed); 2024 Apr; 29(4):136. PubMed ID: 38682184
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
